STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

Magnus Nylén

MD.

Magnus Nyhlén, physician, entrepreneur and founder of Yazen. He has more than 25 years’ experience in building companies within digital healthcare and education.

LinkedIn logo
Portrait imageOrange stylized human head with colorful flowers and vines growing out from the top and back.

With an academic background in computer science and later in medicine, Magnus Nyhlén has throughout his career been driven by the vision of improving and expanding access to healthcare through digitalisation. He strongly believes that digital solutions can provide patients with better support and a deeper understanding of their health – empowering them to take a more active role in their care and achieve better outcomes.

His entrepreneurial journey began in 2013 when he founded MinDoktor, a milestone in the digital transformation of Swedish healthcare. Since then, Magnus has played a central role in several companies that have shaped the future of digital healthcare, including LUVIT, MinDoktor, Blodtrycksdoktorn, Docly and Yazen. With more than 25 years of experience in building and leading businesses within digital education and healthcare, he brings a unique blend of technical, medical and entrepreneurial expertise.

Articles by

Magnus Nylén

Incretin hormone therapy: effective, supervised, and essential for long-term weight loss success

A long-term, individualised weight loss programme for lasting change

Yazen’s evidence-based approach is rooted in science, with research showing that long-term behavioural changes lead to better weight loss maintenance and improved health. Our multidisciplinary programme incorporates these proven methods to ensure sustainable weight management for our patients.

Personalised long-term support for sustainable weight loss.

At Yazen, sustainable weight loss is achieved through a comprehensive, long-term approach, combining a multidisciplinary team of professionals to provide personalised support. Our focus on continuous care, motivation, and tailored strategies helps 70% of patients stay committed to their GLP-1 therapy journey after one year, promoting lasting health and weight maintenance.